# The Veterinary Medicines (Amendment etc.) Regulations 2024, Regulation 165: New paragraph 7A


After paragraph 7 insert—
“Application for a marketing authorisation for specific applications
7A. The fee for an application for a marketing authorisation which involves one or more of the following is £45,000—
(a) any biotechnical process involving recombinant DNA or the controlled expression of genes;
(b) a veterinary medicinal product containing a new active substance;
(c) a biopharmaceutical product.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2024/9780348258523/regulation/165 (the official version)
Page: https://openlegislation.uk/draft-veterinary-medicines-amendment-etc-regulations-2024/regulation-165
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.